Magnetar Financial LLC Grows Stock Holdings in DENTSPLY SIRONA Inc. $XRAY

Magnetar Financial LLC grew its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 539.9% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 205,549 shares of the medical instruments supplier’s stock after acquiring an additional 173,428 shares during the period. Magnetar Financial LLC’s holdings in DENTSPLY SIRONA were worth $2,608,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in XRAY. Mitsubishi UFJ Trust & Banking Corp increased its stake in DENTSPLY SIRONA by 1,836.7% during the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 105,938 shares of the medical instruments supplier’s stock worth $1,344,000 after acquiring an additional 100,468 shares during the last quarter. Commonwealth Equity Services LLC boosted its holdings in shares of DENTSPLY SIRONA by 38.4% in the 3rd quarter. Commonwealth Equity Services LLC now owns 804,934 shares of the medical instruments supplier’s stock worth $10,215,000 after purchasing an additional 223,339 shares during the period. CWM LLC raised its holdings in DENTSPLY SIRONA by 84.3% during the 3rd quarter. CWM LLC now owns 420,470 shares of the medical instruments supplier’s stock valued at $5,336,000 after buying an additional 192,373 shares during the period. Advisors Asset Management Inc. lifted its position in DENTSPLY SIRONA by 42.8% in the third quarter. Advisors Asset Management Inc. now owns 348,989 shares of the medical instruments supplier’s stock worth $4,429,000 after buying an additional 104,588 shares during the last quarter. Finally, Allianz Asset Management GmbH boosted its stake in DENTSPLY SIRONA by 63.6% during the third quarter. Allianz Asset Management GmbH now owns 1,355,643 shares of the medical instruments supplier’s stock worth $17,203,000 after buying an additional 526,973 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director James D. Forbes purchased 5,000 shares of the business’s stock in a transaction dated Monday, March 9th. The shares were purchased at an average price of $12.48 per share, for a total transaction of $62,400.00. Following the completion of the purchase, the director owned 10,000 shares in the company, valued at approximately $124,800. This represents a 100.00% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Gregory T. Lucier acquired 15,000 shares of the firm’s stock in a transaction that occurred on Monday, March 9th. The stock was purchased at an average price of $12.45 per share, with a total value of $186,750.00. Following the completion of the acquisition, the director directly owned 65,000 shares of the company’s stock, valued at $809,250. This represents a 30.00% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders have acquired 70,000 shares of company stock valued at $956,437. 0.50% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Price Performance

Shares of XRAY stock opened at $11.80 on Friday. The company has a debt-to-equity ratio of 1.50, a current ratio of 1.51 and a quick ratio of 1.03. The company has a market capitalization of $2.36 billion, a P/E ratio of -3.93, a P/E/G ratio of 1.49 and a beta of 0.97. The company’s 50-day simple moving average is $12.72 and its two-hundred day simple moving average is $12.43. DENTSPLY SIRONA Inc. has a one year low of $9.85 and a one year high of $17.18.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, February 26th. The medical instruments supplier reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.28 by ($0.01). The company had revenue of $961.00 million for the quarter, compared to the consensus estimate of $926.40 million. DENTSPLY SIRONA had a negative net margin of 16.25% and a positive return on equity of 18.85%. The business’s revenue was up 6.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.26 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on XRAY shares. Barclays began coverage on shares of DENTSPLY SIRONA in a research note on Monday, December 8th. They issued an “underweight” rating and a $12.00 target price on the stock. Barrington Research raised their price objective on shares of DENTSPLY SIRONA from $14.00 to $17.00 and gave the stock an “outperform” rating in a research note on Monday, March 2nd. Bank of America upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and boosted their target price for the company from $13.00 to $17.00 in a research report on Thursday, February 19th. Zacks Research upgraded DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a report on Monday, March 2nd. Finally, Wells Fargo & Company raised their price target on DENTSPLY SIRONA from $12.00 to $13.00 and gave the stock an “equal weight” rating in a research note on Friday, February 27th. Three investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $14.42.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.